(Q44663610)

5 December 2017

title

Follow-up nationwide survey on predictive genetic testing for late-onset hereditary neurological diseases in Japan (English)

1 reference

5 December 2017

Keiko Tanaka

1

1 reference

5 December 2017

Yoshiki Sekijima

2

1 reference

5 December 2017

Kunihiro Yoshida

3

1 reference

5 December 2017

Mariko Tamai

4

1 reference

5 December 2017

Tomoki Kosho

5

1 reference

5 December 2017

Akihiro Sakurai

6

1 reference

5 December 2017

Keiko Wakui

7

1 reference

5 December 2017

Shu-ichi Ikeda

8

1 reference

5 December 2017

Yoshimitsu Fukushima

9

1 reference

5 December 2017

publication date

2 May 2013

1 reference

Journal of Human Genetics

5 December 2017

published in

1 reference

5 December 2017

volume

58

1 reference

5 December 2017

issue

8

1 reference

5 December 2017

page(s)

560-563

1 reference

Predictive genetic tests in neurodegenerative disorders: a methodological approach integrating psychological counseling for at-risk individuals and referring clinicians

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.34

Presymptomatic tests in Huntington's disease and dominant ataxias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.34

Predictive testing for Huntington's disease: ten years' experience in two Italian centres

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.34

Long-term outcome of presymptomatic testing in Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.34

Presymptomatic testing in Huntington's disease and autosomal dominant cerebellar ataxias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.34

Decreasing uptake of predictive testing for Huntington's disease in a German centre: 12 years' experience (1993-2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.34

Paradox of a better test for Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.34

Experience over fifteen years with a protocol for predictive testing for Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.34

Presymptomatic diagnosis in Huntington's disease: the Mexican experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.34

Presymptomatic testing for neurogenetic diseases in Brazil: assessing who seeks and who follows through with testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.34

Psychological follow-up of presymptomatic genetic testing for spinocerebellar ataxia type 2 (SCA2) in Cuba.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.34

Ten years of experience with liver transplantation for familial amyloid polyneuropathy in Japan: outcomes of living donor liver transplantations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.34

Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.34

Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.34

Nationwide survey on predictive genetic testing for late-onset, incurable neurological diseases in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.34

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/JHG.2013.34

1 reference

5 December 2017

1 reference